Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
FDA Approves Zyn Pouches For Sale As Less Harmful Alternative To Cigarettes
 · 1dStocktwits on MSN
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Philip Morris confirms FDA authorizes ZYN nicotine pouches
The Food and Drug Administration has authorized ZYN nicotine pouches, “making ZYN the first and only authorized nicotine pouch in the United
Philip Morris Shares Advance 1% After FDA Authorizes Marketing of Zyn
Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday morning. It is up 28% over the past 12 months.
FDA authorizes marketing of nicotine pouches for the first time
These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.
STAT1d
FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
FDA Authorizes All ZYN Nicotine Pouch Products Marketed By Swedish Match In U.S.
The U.S. Food and Drug Administration has authorized all ZYN Nicotine Pouch Products Currently Marketed by Swedish Match, a
Convenience Store News1d
FDA Authorizes First Nicotine Pouch
The Food and Drug Administration issued marketing granted orders to 20 Zyn nicotine pouch products. The announcement on Thursday marks the first nicotine pouch product to be authorized by the FDA.
FDA officially authorizes Zyn nicotine pouches for sale following health review
The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive scientific review" about their safety.
Philip Morris: Shift To Smoke-Free Sparks Steady Dividend Growth
Learn how Philip Morris International plans to shift to smoke-free products by 2030 to mitigate risks, boost profits, and achieve strong financial growth.
Philip Morris stock rises on FDA's first nicotine pouch approval
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, the data show that these nicotine pouch products meet that bar by benefiting adults who use cigarettes and/or smokeless tobacco products and completely switch to these products.”
Zyn’s Flavored Nicotine Pouches Win Marketing Approval From FDA
The US Food and Drug Administration approved the marketing of 20 Zyn products to adults, the first time it has authorized nicotine pouches.
FDA will allow Zyn nicotine pouches to stay on the market
Zyn products will be allowed to stay on the market after federal health officials said Thursday that the popular nicotine pouches can help adult smokers cut back or switch completely.